The biological clock doesn't stop working for those with Alzheimer's disease, but it does detach from sleep wake cycles, a new report claims.
Researchers report of creating two new mouse models of Alzheimer's disease. They believe the models could potentially revolutionize research into the neurodegenerative disease.
Researchers identify compounds that stabilize retromer protein complex and protects neurons from amyloid-beta.
Researchers have defined a sub-type of Alzheimer's disease which is relatively widespread, yet not well recognized or treated appropriately.
In animal studies, researchers have identified a compound which reduces amyloid beta proteins by more than half.
Amyloid beta has been implicated in blocking endocannabinoids in the hippocampus; impairing learning and memory long before Alzheimer's plaques form in the brain.
RU 505, a compound which could halt the progression of Alzheimer's may also be able to prevent abnormal blood clots in the brain, researchers report.
A new study reports extremely low levels of THC could slow, or even halt, the progression of Alzheimer's disease.
Researchers report they have discovered a defect in a cell signaling pathway which contributes to the build-up of amyloid beta in those with Alzheimer's.
Low levels of progranulin shown to increase the formation of amyloid beta plaques and worsen memory deficits in mouse models of Alzheimer's disease.
Using an innovative culture system, researchers provide evidence supporting the amyloid hypothesis of Alzheimer's disease.